跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
善宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Octreotide Acetate Injection
Approved
化学药品
Octreotide Acetate Injection
Novartis Pharma Schweiz AG
🇨🇳 National Medical Products Administration
Approval Date
Sep 27, 2023
Approval ID
8Xx2nxufGgx
Company
Novartis Pharma Schweiz AG
Type
化学药品
Approval Details
Approval Id
8Xx2nxufGgx
Approval Number
国药准字HJ20150364
Generic Name
醋酸奥曲肽注射液
Generic Name En
Octreotide Acetate Injection
Trade Name
善宁
Drug Type
化学药品
Dosage Form
注射剂
Strength
1ml : 0.1mg ( 以C₄₉H₆₆N₁₀O₁₀S₂计)
Reg Date
2023-09-27
Expired Date
2028-09-26
Company Name
Novartis Pharma Schweiz AG
Production Company Name
DELPHARM DIJON
Company Detail Path
/organization/novartis-pharma-schweiz-ag
Production Company Detail Path
/organization/delpharm-dijon
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 27, 2023
Approval ID
8Xx2nxufGgx
Type
化学药品
Back to NMPA Approvals